ADAPTIMMUNE THERAPEUTICS PLC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K, a 50.00% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $9.00K, a 87.84% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $1.00K, a 99.38% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $2.00K, a 85.71% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for fiscal 2024 was $77.00K, a 69.92% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for fiscal 2023 was $256.00K, a 412.00% increase from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for fiscal 2022 was $50.00K, a 93.41% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC stock issued during period, value, stock options exercised for fiscal 2021 was $759.00K, a 86.60% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $9.00K 10-Q · filed 2025-08-13 | |
| 2024-12-31 | $77.00K 10-K · filed 2025-03-24 | |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.00K 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $74.00K 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $256.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $161.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $14.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $8.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $50.00K 10-K · filed 2025-03-24 | |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $35.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $759.00K 10-K · filed 2024-03-06 | |
| 2021-09-30 | $129.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $43.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $535.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $5.66M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $462.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $4.18M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $894.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $366.00K 10-K · filed 2022-03-14 | |
| 2019-06-30 | $330.00K 10-Q · filed 2020-11-05 | $980.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $36.00K 10-Q · filed 2020-11-05 | $1.54M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.04M 10-K · filed 2021-02-25 |
| 2018-09-30 | $510.00K 10-Q · filed 2019-11-06 | $2.93M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $889.00K 10-Q · filed 2019-11-06 | $2.79M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-03-31 | $1.53M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $401.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | |
| 2016-12-31 | $17.00K 10-K · filed 2019-02-27 | |
| 2014-06-30 | $192.00K 10-K · filed 2017-03-13 |